We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Novel Light-Based Technique With 90% Accuracy Rate to Revolutionize Cancer Diagnosis

By LabMedica International staff writers
Posted on 03 Sep 2024

A quicker, cheaper, and less painful cancer detection technique developed using light has the potential to revolutionize cancer diagnosis, early detection, and monitoring. More...

Researchers at Aston Institute of Photonic Technologies (AiPT, Birmingham, UK) have developed a new technique for analyzing crystals in dehydrated blood. Utilizing a novel polarization-based image reconstruction method, the team examined polycrystalline structures within dried blood samples. This analysis is vital as proteins in the blood undergo structural transformations in their tertiary (unique 3D shape) and quaternary forms (how multiple proteins assemble) during the onset of diseases such as cancer.

The new technique allows for a comprehensive layer-by-layer analysis of dry blood smears, a critical factor in distinguishing between healthy and cancerous samples. The research involved 108 blood film samples divided into three equal groups: healthy individuals, prostate cancer patients, and patients with aggressive cancer cells. The findings published in the Nature journal Scientific Reports showed a 90% accuracy rate in early diagnosis and classification of cancer, surpassing the efficacy of traditional screening methods. Moreover, this approach uses blood samples rather than tissue biopsies, making it a less invasive and safer option for patients.

"Our study introduces a pioneering technique to the liquid biopsy domain, aligning with the ongoing quest for non-invasive, reliable and efficient diagnostic methods,” said AiPT Professor Igor Meglinski. “A key advancement in our study is the characterization of the mean, variance, skewness, and kurtosis of distributions with the cells which is crucial for identifying significant differences between healthy and cancerous samples. This breakthrough opens new avenues for cancer diagnosis and monitoring, representing a substantial leap forward in personalized medicine and oncology."

Related Links:
AiPT


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical Abstract (Ziegler, AG., Rewers, M.J., Achenbach, P. et al. Diabetologia (2026). https://doi.org/10.1007/s00125-026-06841-z)

International Consensus Guidance Outlines General Population Screening for Early-Stage Type 1 Diabetes

Type 1 diabetes (T1D) is an autoimmune disease that can develop in childhood or adulthood and affects an estimated 9.5 million people worldwide. Its complications range from acute diabetic ketoacidosis... Read more

Microbiology

view channel
Image: The current BDBV outbreak in the DRC underscores response challenges for rare, severe infections (Image Credit: 123RF)

Research Strengthens Bundibugyo Virus Outbreak Readiness with Faster Diagnostics

Bundibugyo virus (BDBV), a species of ebolavirus, causes severe hemorrhagic disease and can be difficult to diagnose rapidly during outbreaks. Recent regulatory changes have further complicated swift deployment... Read more

Technology

view channel
Image: The 5811 R retains the performance and versatility of its predecessor while adding a new design, a refreshed user interface, and updated sustainable cooling technology. (Photo courtesy of Eppendorf)

New Multipurpose Centrifuge Combines High Capacity with Sustainable Cooling

Laboratories often need centrifugation that accommodates multiple vessel formats while maintaining controlled temperatures to protect sensitive samples. Intuitive controls and repeatable operation can... Read more

Industry

view channel
Image: The combined offering is designed to streamline workflows and support multicolor applications used in leukemia, lymphoma, and measurable residual disease assessment in specialized clinical settings

Sysmex and Cytek Collaboration Expands Access to Advanced Clinical Flow Cytometry

Sysmex Europe SE (Hamburg, Germany) and Cytek Biosciences (Fremont, CA, USA) are partnering across more than a dozen European countries to expand access to advanced clinical flow cytometry.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.